[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Texas Christian University\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":133},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,4,0,[8,47,77,108],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":17,"sex":18,"minAge":19,"maxAge":4,"enrollmentInfo":20,"targetDuration":4,"studyType":23,"phases":24,"briefSummary":26,"conditions":27,"keywords":31,"overallStatus":34,"whyStopped":4,"lastUpdateSubmitDate":35,"lastUpdatePostDateStruct":36,"startDateStruct":39,"completionDateStruct":41,"leadSponsor":43,"locationsCount":46},"100633604","justice-community-overdose-innovation-network-ii-tcu-hub-100633604",false,"NCT07528846","Justice Community Overdose Innovation Network II TCU Hub","Justice Community Overdose Innovation Network II TCU Hub: TCU Building Resilient Initiatives for Deflection Through Greater Engagement Project (TCU BRIDGE to Deflection Project)","JCOIN II TCU","Staff\n\nInclusion Criteria:\n\n* Directly involved in Deflection services, including:\n* Making referrals (e.g., law enforcement, first responders, community agencies) \\& Providing services to participants (e.g., case managers, peer specialists, coordinators);\n* Aged 18 years or older;\n* Able to complete surveys in English;\n* Willing to provide informed consent\n\nExclusion Criteria:\n\n* Not affiliated with a participating Deflection agency;\n* No role in Deflection referral or service delivery;\n* Under age 18;\n* Unable or unwilling to provide informed consent\n\nClients\n\nInclusion Criteria:\n\n* Aged 18 years or older;\n* Enrolled in a Deflection program within a participating community;\n* Between 1 and 12 months post-enrollment at time of recruitment;\n* Documented history of substance use disorder (SUD) or risk for SUD;\n* Priority for individuals reporting opioid and\u002For stimulant use within the past year;\n* Able to complete survey and\u002For interview; Willing to provide informed consent\n\nExclusion Criteria:\n\n* Under age 18;\n* Not enrolled in a Deflection program;\n* Insufficient exposure to Deflection (\\\u003C1 month);\n* Unable or unwilling to provide informed consent\n\nCitizens\n\nInclusion Criteria:\n\n* Aged 18 years or older;\n* Resident of a participating community;\n* Represents general community population (including individuals with or without lived experience of SUD\u002FCLS involvement);\n* Able to participate in: Surveys and\u002For Community Listening Sessions;\n* Willing to provide informed consent\n\nExclusion Criteria:\n\n* Under age 18;\n* Not residing in a participating community;\n* Unable or unwilling to provide informed consent\n\nWorkgroup\n\nInclusion Criteria:\n\n* Aged 18 years or older;\n* Identified as a community or agency leader\u002Fstakeholder involved in Deflection programming;\n* Member of a DAG within a participating community;\n* Represents one of the required stakeholder roles: Law enforcement leadership or staff, Behavioral health leadership or staff Health professional, Community representative (citizen);\n* Able to participate in meetings, surveys, and\u002For focus groups;\n* Willing to provide informed consent\n\nExclusion Criteria:\n\n* Not part of a DAG in a participating community;\n* Does not hold a role relevant to Deflection leadership or decision-making;\n* Under age 18;\n* Unable or unwilling to provide informed consent",true,"ALL","18 Years",{"count":21,"type":22},1620,"ESTIMATED","INTERVENTIONAL",[25],"NA","The current study proposes to use a Hybrid Type 3 implementation research strategy to: 1) Significantly enhance our understanding of public health outcomes \\[e.g., overdose incidents and substance-use (SU)-related Emergency Medical Service (EMS) contacts\\] and public safety outcomes (e.g., drug-related arrests) associated with Deflection and Pre-Arrest Diversion initiatives (DPAD, hereafter referred to as Deflection); and 2) Create a lasting contribution to the fields of research focused on SU and the criminal legal system (CLS) by advancing knowledge of effective implementation strategies involving the critical role of community engagement in Deflection. The highly experienced team of Multiple PIs, senior-level collaborators from both Deflection and Community Behavioral Health (CBH), state-level evaluation partners, a national stakeholder advisory group, and CLS and behavioral health partners within each community have teamed up to carry out the proposed project. The study approach uses a hybrid implementation-effectiveness design to examine strategies to improve opioid and stimulant relevant outcomes, and specifically proposes to test the implementation-effectiveness of 2 strategy bundles to promote Deflection models through a CORE community engagement bundle (designed to facilitate community stakeholder engagement) and ENHANCED community engagement bundle (CORE plus a component to systematically involve community advocates) on improving implementation as well as public safety and health outcomes. The proposed randomized control trial includes a total of 20 geographically distinct clinical research performance sites (i.e., 20 communities spanning 5 states; New Mexico, Illinois, Wisconsin, Colorado, and Pennsylvania), with 3-5 communities per state and the inclusion of key CLS and CBH stakeholders within each site. The large scope of the project will maximize potential generalizability of study results and sustainability of implementation strategies.",[28,29,30],"Substance Use Disorder (SUD)","Drug Overdose","Criminal Behavior",[32,33],"deflection","pre-arrest diversion","NOT_YET_RECRUITING","2026-04-07",{"date":37,"type":38},"2026-04-14","ACTUAL",{"date":40,"type":22},"2026-07",{"date":42,"type":22},"2029-05",{"name":44,"class":45},"Texas Christian University","OTHER",1,{"id":48,"slug":49,"hasResults":11,"nctId":50,"briefTitle":51,"officialTitle":52,"acronym":4,"eligibilityCriteria":53,"healthyVolunteers":17,"sex":18,"minAge":19,"maxAge":4,"enrollmentInfo":54,"targetDuration":4,"studyType":23,"phases":56,"briefSummary":58,"conditions":59,"keywords":61,"overallStatus":67,"whyStopped":4,"lastUpdateSubmitDate":68,"lastUpdatePostDateStruct":69,"startDateStruct":71,"completionDateStruct":73,"leadSponsor":75,"locationsCount":76},"100621954","phase-1-exploration-of-an-online-education-program-to-support-caregivers-knowledge-transfer-100621954","NCT07377331","Exploration of an Online Education Program to Support Caregivers' Knowledge Transfer","Exploration of Structure Retrieval Practice to Support Caregivers' Knowledge Transfer","Inclusion Criteria:\n\n* informal caregivers\n* 18+ years old\n* Read and speak English\n* free of cognitive impairments that prevent consent and\u002For completing experimental tasks\n* remote participants need access to a tablet, laptop, or desktop computer to complete tasks.\n\nExclusion Criteria:\n\n* professional caregivers\n* former caregivers who are not currently caring for someone living with dementia\n* caregivers providing assistance to someone with normal cognition",{"count":55,"type":22},60,[57],"PHASE1","The overarching goal of this work is to determine methods that improve caregiver education about the behavioral and psychological symptoms (BPSD) of dementia. The specific goal of this project is to extend our prior work to evaluate the impact of our educational intervention on caregivers' ability to transfer knowledge about the management of ADRD to real-world applied examples.",[60],"Dementia",[62,63,64,65,66],"dementia","caregiving","knowledge","transfer","behaviorial problems","RECRUITING","2026-01-22",{"date":70,"type":38},"2026-01-29",{"date":72,"type":38},"2025-11-01",{"date":74,"type":22},"2026-08-15",{"name":44,"class":45},2,{"id":78,"slug":4,"hasResults":11,"nctId":79,"briefTitle":80,"officialTitle":81,"acronym":4,"eligibilityCriteria":82,"healthyVolunteers":11,"sex":83,"minAge":19,"maxAge":84,"enrollmentInfo":85,"targetDuration":4,"studyType":23,"phases":87,"briefSummary":89,"conditions":90,"keywords":97,"overallStatus":67,"whyStopped":4,"lastUpdateSubmitDate":101,"lastUpdatePostDateStruct":102,"startDateStruct":104,"completionDateStruct":105,"leadSponsor":107,"locationsCount":46},"100613801","NCT07271316","Alii Supplement Study","Birth Control Supplement Study","Inclusion Criteria:\n\n* Participants must be on the hormonal birth control pill as the investigators are testing the effectiveness of a supplement for women who take the hormonal birth control pill\n* Participants must be willing to complete a follow up survey as this study will be multiple parts\n* Participants must be willing to take a daily supplement as this study is testing how a supplement influences a variety of psychological outcomes\n* Participants must be on the hormonal birth control pill for at least six months as participants who have been on the pill for less than 6 months may not be experiencing nutritional depletion yet\n* If the investigators are able to do so, the investigators will only recruit participants who take the one-month hormonal birth control pill rather than the three month hormonal birth control pill, as the investigators are going to have participants come in after 28 days (day 2 of pack 1 and day 2 of pack 2) and participants on the three-month HBC pill may be on a 21 day cycle.\n* Participants must have no food or medication allergies that will prevent the participants from safely taking the supplement\n* Participants must not be taking any vitamins or participant must report willingness to abstain from taking vitamins during the study as individuals who are already taking vitamins may not be experiencing nutritional depletion associated with hormonal birth control\n* If the investigators have the ability to do so, the investigators will only recruit participants who are not taking medications. Participants on various medications (e.g., SSRIs, ADHD medications, etc.) may report differing psychological states due to their medications, rather than the supplement. Therefore, it would be best to exclude those individuals if possible.\n\nExclusion Criteria:\n\n* Participants cannot be naturally cycling as the investigators are testing a supplement for women on hormonal birth control\n* Participants cannot be unwilling to complete a follow up study because this is a multi-part study\n* Participants cannot be unwilling to take a supplement because the study centers around taking a supplement\n* Participants cannot be on the hormonal birth control pill for less than 6 months as participants who have been on the pill for less than 6 months may not be experiencing nutritional depletion yet\n* If the investigators are able to do so, participants cannot take the three month hormonal birth control pill, as the investigators are going to have participants come in after 28 days (day 2 of pack 1 and day 2 of pack 2) and participants on the three-month HBC pill may be on a 21 day cycle.\n* Participants cannot have any food or medication allergies that will prevent the participants from safely taking the supplement\n* Participants must not be taking any vitamins or participants must report willingness to abstain from taking vitamins during the study as individuals who are already taking vitamins may not be experiencing nutritional depletion associated with hormonal birth control\n* If the investigators have the ability to do so, the investigators will only recruit participants who are not taking medications. Participants on various medications (e.g., SSRIs, ADHD medications, etc.) may report differing psychological states due to their medications, rather than the supplement. Therefore, it would be best to exclude those individuals if possible.","FEMALE","25 Years",{"count":86,"type":22},68,[88],"PHASE2","The goal of this clinical trial is to learn if the Alii Supplement can be used to reduce symptoms related to nutritional depletion in hormonal birth control pill users. The main questions it aims to answer are:\n\nDoes usage of the supplement increase happiness, decrease perceived vulnerability to disease, increase digestive health, decrease mood swings, and increase energy?\n\nThe investigators will compare the Alii Supplement to a placebo (a capsule that contains no drug) to see if the Alii Supplement works to reduce symptoms associated with nutritional depletion.\n\nParticipants will:\n\nTake the placebo or Alii Supplement everyday for 28 days and visit the research office twice to fill out an online survey comprising of items examining the main outcome measures.",[91,92,93,94,95,96],"Nutrient Deficiency","Happiness","Digestive Health","Vulnerability to Disease","Mood Swings","Energy",[98,99,100],"Hormonal Birth Control","Nutritional Depletion","Dietary Supplement","2026-01-12",{"date":103,"type":38},"2026-01-14",{"date":101,"type":38},{"date":106,"type":22},"2026-04-29",{"name":44,"class":45},{"id":109,"slug":110,"hasResults":11,"nctId":111,"briefTitle":112,"officialTitle":112,"acronym":4,"eligibilityCriteria":113,"healthyVolunteers":17,"sex":18,"minAge":19,"maxAge":4,"enrollmentInfo":114,"targetDuration":4,"studyType":23,"phases":116,"briefSummary":118,"conditions":119,"keywords":122,"overallStatus":67,"whyStopped":4,"lastUpdateSubmitDate":125,"lastUpdatePostDateStruct":126,"startDateStruct":128,"completionDateStruct":130,"leadSponsor":132,"locationsCount":46},"100604097","phase-3-translaryngeal-vibration-for-hyperfunctional-voice-disorders-100604097","NCT07145086","Translaryngeal Vibration for Hyperfunctional Voice Disorders","Inclusion Criteria:\n\n* a) diagnosis by an otolaryngologist of hyperfunctional dysphonia (MTD) without benign mid-membranous lesion (i.e., primary MTD or non-phonotraumatic hyperfunction) with and a recommendation for voice therapy, ((b) confirmation of dysphonia by a comprehensive voice evaluation conducted by a speech-language pathologist with experience in the evaluation and treatment of voice disordered populations, (c) to prevent floor effects of our primary outcome variable, participants will be required to exhibit a pre-treatment VHI score of \\>20, as this is the upper range for normal cutoff values in studies which have demonstrated high sensitivity and specificity for this tool (Behlau et al., 2016), (d) 18 years of age or older, (e) no history of local vibration therapy as part of a rehabilitation treatment program.\n\nExclusion Criteria:\n\n* Unable to receive vibration to neck area",{"count":115,"type":22},30,[117],"PHASE3","Contemporary treatments for hyperfunctional voice disorders such as muscle tension dysphonia (MTD) are effective but typically do not restore voice handicap or voice function to normal thresholds. Recent reports of vibration as a voice therapy modality have been published, but many questions remain about the efficacy of this tool. The current project addresses these problems through a blinded and randomized controlled trial to investigate the efficacy of local translaryngeal vibration for MTD and the dose-response relationship of this modality when compared to treatment without vibration.",[120,121],"Dysphonia","Muscle Tension Dysphonia",[120,121,123,124],"Voice Therapy","Vibration","2025-08-20",{"date":127,"type":38},"2025-08-28",{"date":129,"type":38},"2024-09-01",{"date":131,"type":22},"2027-08-31",{"name":44,"class":45},""]